In a forthcoming announcement, the Trump administration is expected to reveal findings linking the use of Tylenol during pregnancy to an increased risk of autism in children. This announcement, teased by President Trump, is said to be significant and is anticipated to generate considerable discussion on the implications of prescription drug use and autism diagnosis. Officials have indicated that the upcoming news could mark a major shift in understanding autism and the potential effects of common medications during pregnancy. Parents are being warned to be cautious, as this announcement may influence health guidelines and parenting choices.